Aptimmune Biologics, Inc. announced it raised $2.42 Million in an amended filing from an offering of $3.25 Million

Mar 24, 2016•over 9 years ago

Amount Raised

$2.42 Million

Round Type

seed

ChampaignBiotechnology

Company Information

Company

Aptimmune Biologics, Inc.

Location

60 HAZELWOOD DRIVE

Champaign, Illinois, United States

About

Aptimmune specializes in the development and application of prophylactic measures against viral diseases of swine.